James W. Brodack
About
In The Last Decade
James W. Brodack
18 papers receiving 833 citations
Peers
Comparison fields: 5 of 81
- Radiology, Nuclear Medicine and Imaging 629
- Oncology 179
- Genetics 172
- Pulmonary and Respiratory Medicine 138
- Cancer Research 135
Countries citing papers authored by James W. Brodack
This map shows the geographic impact of James W. Brodack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Brodack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Brodack more than expected).
Fields of papers citing papers by James W. Brodack
This network shows the impact of papers produced by James W. Brodack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Brodack. The network helps show where James W. Brodack may publish in the future.
Co-authorship network of co-authors of James W. Brodack
This figure shows the co-authorship network connecting the top 25 collaborators of James W. Brodack. A scholar is included among the top collaborators of James W. Brodack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Brodack. James W. Brodack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. | 80 |
| 3 | Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. | 192 |
| 4 | 12 | |
| 5 | 6 | |
| 6 | 25 | |
| 7 | 20 | |
| 8 | 49 | |
| 9 | 19 | |
| 10 | 38 | |
| 11 | 19 | |
| 12 | 47 | |
| 13 | Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16 alpha-fluoroestradiol-17 beta. | 33 |
| 14 | 60 | |
| 15 | 155 | |
| 16 | The investigation of radiopharmaceutical components by fast atom bombardment mass spectrometry: the identification of Tc-HIDA and the epimers of Tc-CO2DADS. | 15 |
| 17 | 15 | |
| 18 | Chemical and in vivo studies of the anion oxo[N,N'-ethylenebis(2-mercaptoacetimido)]Technetate(V). | 34 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.